Finding cancer
is not enough.

Medical imaging is finding cancers and pre-cancers at record rates.

Yet, current diagnostics can't reliably predict which ones are high risk.

This creates a gap: patients suffer over-treatment or miss the window for early intervention.

Every pre-cancer leaves a molecular trace of where it's heading.

We read that trace to tell clinicians which patients need action, and which don't.

Our mission is to make every cancer treatable at the pre-cancer stage.